K. Gooch

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Karen Gooch, K. Gooch, K. E. Gooch, K Gooch, Karen E. Gooch, Karen E Gooch
Publication record
37 papers · 1,498 citations · H-index 19

PAPERS

A systems biology approach to define SARS-CoV-2 correlates of protection
20251 citationsauthor #5
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
202315 citationsauthor #9
105 What is the Association Between Smoking or Vaping and Covid-19 Susceptibility?
20230 citationsauthor #5
106 Establishing a Physiologically Relevant in Vitro Airway Model to Assess the Impacts of Environmental Exposures, Like Smoking, on Covid-19 Susceptibility.
20230 citationsauthor #6
Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
20239 citationsauthor #14
Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
202226 citationsauthor #9
Activity of a Carbohydrate-Binding Module Therapy, Neumifil, against SARS-CoV-2 Disease in a Hamster Model of Infection
20228 citationsauthor #7
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
2021127 citationsauthor #90
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
202119 citationsauthor #1
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
2021145 citationsauthor #6
Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection
202120 citationsauthor #13
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
202127 citationsauthor #2
High dose aerosol challenge with Mycobacterium tuberculosis fails to overcome BCG vaccination-induced protection in cynomolgus macaques of Chinese origin: implications of natural resistance for TB vaccine evaluation.
20212 citationsauthor #3
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
20214 citationsauthor #3
Convalescence from prototype SARS-CoV-2 protects Syrian hamsters from disease caused by the Omicron variant
202117 citationsauthor #12
Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
20217 citationsauthor #2
Acute kidney injury in a mouse model of meningococcal disease
20212 citationsauthor #6
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
202113 citationsauthor #4
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
2021148 citationsauthor #21
ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
20218 citationsauthor #4
Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge
202043 citationsauthor #17
Immunological and pathological outcomes of SARS-CoV-2 challenge after formalin-inactivated vaccine immunisation of ferrets and rhesus macaques
20206 citationsauthor #2
mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
202050 citationsauthor #2
Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19
20207 citationsauthor #6
Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory Samples
2019151 citationsauthor #14
Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques
201923 citationsauthor #2
Heterosubtypic cross-protection correlates with cross-reactive interferon-gamma-secreting lymphocytes in the ferret model of influenza
201926 citationsauthor #1
Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung
201824 citationsauthor #8
Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza
201713 citationsauthor #7
An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques
201728 citationsauthor #9
Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection
201629 citationsauthor #4
Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques
201393 citationsauthor #4
by Aerosol to the Lungs of Macaques Tuberculosis Vaccine, MVA85A, Delivered Immunogenicity of a Candidate Evaluation of the Safety and
20130 citationsauthor #8
Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing
2010133 citationsauthor #8
Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.
200968 citationsauthor #10
Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge.
200631 citationsauthor #6
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
2005182 citationsauthor #4

TIMELINE

2005 182 citations

2006 31 citations

2009 68 citations

2010 133 citations

2013 93 citations

2016 29 citations

2017 41 citations

2018 24 citations

2019 200 citations

2020 106 citations

2021 539 citations

2022 34 citations

2023 24 citations

2025 1 citations

K. Gooch

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT